Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo Validation

Agency Information

HEALTH AND HUMAN SERVICES, DEPARTMENT OF.FOOD AND DRUG ADMINISTRATION.FDA OFFICE OF ACQ GRANT SVCS

Place of Performance

Nationwide

SAM.gov lists a country but no specific city or state — the work is not tied to one location.

Description

No detailed description available

Important Dates

Posted Date

Aug 26, 2026 12:00 AM

Response Deadline

Sep 10, 2026 7:00 PM

Contact Information

Primary Contact

Kimberly Pennix

Primary Contact

[email protected]

2404029703

Additional Contacts

Ian Weiss

Secondary Contact

[email protected]

3017965728

NAICS Code

541714

Research and Development in Biotechnology (except Nanobiotechnology)

Past winners & typical award amounts

See who won similar contracts and for how much — available with a Kontrakk Pro account.

Sign up

Kontrakk Proposal Preview

Generate professional outreach emails in seconds.

To: [email protected]

Subject: Interest in 75F40126Q00382

Dear Contracting Officer, I am writing to express our interest in the above-referenced solicitation. Our organization has extensive experience delivering similar solutions to federal agencies, and we believe our capabilities align well with the requirements outlined. We would welcome the opportunity to discuss how our team can support this initiative. Please do not hesitate to reach out with any questions or to schedule a capabilities briefing.

Generate proposals instantly

Sign up to create Kontrakk-powered outreach emails and send via Gmail, Outlook, or Yahoo.

Sign up